Product Program year 2020 Source: CMS Open Payments

Allure CRT Pacemaker

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$434,717

1,536 payments

Research payments

$0

0 payments

Through program year 2020, $434,717 in general payments and $0 in research payments were reported against Allure CRT Pacemaker (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $198,052 576
2019 General $236,665 960

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $434,717 1,536 payments
Top recipients General payments · program year 2020
  1. Noah Chelliah Cardiovascular Disease · Grand Forks, ND $16,107 8% · 14 payments
  2. John Ip Clinical Cardiac Electrophysiology · Lansing, MI $14,550 7% · 12 payments
  3. Sanjay Deshpande Clinical Cardiac Electrophysiology · Beloit, WI $12,188 6% · 3 payments
  4. Murlidhar Amin Cardiovascular Disease · Port Arthur, TX $9,598 5% · 17 payments
  5. Sunil Kapur Cardiovascular Disease · Boston, MA $9,469 5% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $120,605 62% · 116 practitioners
  2. Cardiovascular Disease Internal Medicine $66,764 35% · 89 practitioners
  3. Interventional Cardiology Internal Medicine $2,774 1% · 27 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,066 <1% · 7 practitioners
  5. Internal Medicine $553 <1% · 10 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Michigan $27,187 14% · 5 recipients
  2. Texas $17,791 9% · 36 recipients
  3. California $17,437 9% · 15 recipients
  4. North Dakota $16,107 8% · 1 recipient
  5. Connecticut $13,219 7% · 3 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,536 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record